Cost Reduction of Inhaled Tobramycin by Use of Preservative-Free Intravenous Tobramycin Given via Inhalation

Cost Reduction of Inhaled Tobramycin by Use of Preservative-Free Intravenous Tobramycin Given via Inhalation

This study evaluates drug cost outcomes related to automatic therapeutic substitution of branded tobramycin solution for inhalation (TOBI®) with inhaled generic preservative-free intravenous tobramycin (PFIT). A retrospective single-center evaluation of inhaled tobramycin use from 2008 through 2012...

Full description

Bibliographic Details
Main Authors: Timothy P. Gauthier, Justin Wasko, Nathan R. Unger, Lilian M. Abbo, Margaret Fernandez, Laura Aragon
Format: Article
Language:English
Published: MDPI AG 2015-12-01
Series:Antibiotics
Subjects:
inhaled antibiotics
pharmacy
pharmacotherapy
Online Access:http://www.mdpi.com/2079-6382/5/1/2

Internet

http://www.mdpi.com/2079-6382/5/1/2

Similar Items